Pages that link to "Q26992045"
Jump to navigation
Jump to search
The following pages link to How many molecular subtypes? Implications of the unique tumor principle in personalized medicine (Q26992045):
Displaying 50 items.
- Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease (Q24289344) (← links)
- Cancer classification in the genomic era: five contemporary problems (Q26781783) (← links)
- Potential of epigenetic therapies in the management of solid tumors (Q26783134) (← links)
- Inhibition of Topoisomerase (DNA) I (TOP1): DNA Damage Repair and Anticancer Therapy (Q26796576) (← links)
- World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonisation Project: IV. Tissue collection, processing, and storage in endometriosis research (Q26827259) (← links)
- Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression (Q26852716) (← links)
- Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology (Q27011884) (← links)
- Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival (Q28277824) (← links)
- Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features (Q28284149) (← links)
- Colorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology Approach (Q28647615) (← links)
- Staphylococcus aureus in the Intensive Care Unit: Are These Golden Grapes Ripe for a New Approach? (Q30239977) (← links)
- Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis. (Q30244608) (← links)
- Nucleic Acid Aptamers as Potential Therapeutic and Diagnostic Agents for Lymphoma (Q30434521) (← links)
- Discretization of Gene Expression Data Unmasks Molecular Subgroups Recurring in Different Human Cancer Types (Q31122277) (← links)
- Significant Prognostic Features and Patterns of Somatic TP53 Mutations in Human Cancers (Q33565858) (← links)
- Disease and treatment characteristics do not predict symptom occurrence profiles in oncology outpatients receiving chemotherapy (Q33940740) (← links)
- Progress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions (Q34016833) (← links)
- Serrated polyps of the large intestine: current understanding of diagnosis, pathogenesis, and clinical management (Q34034620) (← links)
- Challenges and opportunities in international molecular cancer prevention research: An ASPO Molecular Epidemiology and the Environment and International Cancer Prevention Interest Groups Report. (Q34441501) (← links)
- SMO expression in colorectal cancer: associations with clinical, pathological, and molecular features (Q34458644) (← links)
- Proceedings of the second international molecular pathological epidemiology (MPE) meeting (Q34475686) (← links)
- Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status. (Q34502713) (← links)
- BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients (Q34517338) (← links)
- Structured decision-making: using personalized medicine to improve the value of cancer care (Q34608684) (← links)
- Lifecourse epidemiology and molecular pathological epidemiology. (Q34762152) (← links)
- Expression of uPAR in tumor-associated stromal cells is associated with colorectal cancer patient prognosis: a TMA study (Q35151053) (← links)
- Use of the comet assay technique for quick and reliable prediction of in vitro response to chemotherapeutics in breast and colon cancer. (Q35317195) (← links)
- A Meta-Regression Method for Studying Etiological Heterogeneity Across Disease Subtypes Classified by Multiple Biomarkers. (Q35896952) (← links)
- Personalized radiotherapy: concepts, biomarkers and trial design (Q36235704) (← links)
- Systematic pan-cancer analysis of tumour purity (Q36350773) (← links)
- Accounting for tumor purity improves cancer subtype classification from DNA methylation data (Q36363371) (← links)
- Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis. (Q36416491) (← links)
- Integration of molecular pathology, epidemiology and social science for global precision medicine (Q36463854) (← links)
- Prospective study of family history and colorectal cancer risk by tumor LINE-1 methylation level (Q36535688) (← links)
- Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer. (Q36563705) (← links)
- The sulfatase pathway for estrogen formation: targets for the treatment and diagnosis of hormone-associated tumors (Q36651350) (← links)
- Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status. (Q36675320) (← links)
- Specific mutations in KRAS codons 12 and 13, and patient prognosis in 1075 BRAF wild-type colorectal cancers (Q36761405) (← links)
- Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer (Q36926941) (← links)
- Tissue banking, bioinformatics, and electronic medical records: the front-end requirements for personalized medicine (Q36931470) (← links)
- Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine (Q36968401) (← links)
- A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classification (Q36974863) (← links)
- Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication (Q37075412) (← links)
- Aspirin use and risk of colorectal cancer according to BRAF mutation status (Q37094281) (← links)
- Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial. (Q37360360) (← links)
- Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A. (Q37397814) (← links)
- TP53 mutations in human cancer: database reassessment and prospects for the next decade (Q38199075) (← links)
- Overcoming tumor heterogeneity in the molecular diagnosis of urological cancers (Q38261250) (← links)
- Systems biology meets -omic technologies: novel approaches to biomarker discovery and companion diagnostic development. (Q38264304) (← links)
- Culture of low passage colorectal cancer cells and demonstration of variation in selected tumour marker expression (Q38597963) (← links)